Coldstream Capital Management’s Zimmer Biomet ZBH Stock Holding History

Coldstream Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$376K	Buy	4,158 +1,627	+64%	+$149K	﹤0.01%	844
2025 Q4	$228K	Sell	2,531 -187	-7%	-$17.7K	﹤0.01%	1036
2025 Q3	$268K	Buy	+2,718	New	+$269K	﹤0.01%	991
2025 Q2	–	Sell	-2,885	Closed	-$327K	–	3420
2025 Q1	$327K	Buy	2,885 +78	+3%	+$8.34K	0.01%	777
2024 Q4	$297K	Buy	2,807 +24	+0.9%	+$2.58K	0.01%	832
2024 Q3	$301K	Sell	2,783 -19	-0.7%	-$2.07K	0.01%	841
2024 Q2	$304K	Sell	2,802 -380	-12%	-$44.8K	0.01%	750
2024 Q1	$420K	Buy	3,182 +340	+12%	+$42.5K	0.01%	626
2023 Q4	$346K	Buy	2,842 +170	+6%	+$19K	0.01%	651
2023 Q3	$300K	Buy	2,672 +303	+13%	+$38.5K	0.01%	598
2023 Q2	$345K	Buy	2,369 +13	+0.6%	+$1.77K	0.01%	576
2023 Q1	$304K	Buy	2,356 +25	+1%	+$3.14K	0.01%	623
2022 Q4	$297K	Buy	+2,331	New	+$271K	0.01%	600
2022 Q2	–	Sell	-1,945	Closed	-$249K	–	857
2022 Q1	$249K	Sell	1,945 -123	-6%	-$14.8K	0.01%	654
2021 Q4	$255K	Buy	+2,068	New	+$271K	0.01%	689

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Coldstream Capital Management's ZBH Position: Q1 2026 in Review

Coldstream Capital Management increased its Zimmer Biomet (ZBH) stake by 64% in Q1 2026, buying an estimated $149K and bringing the position to 4,158 shares worth $376K. The position accounts for ﹤0.01% of the portfolio, ranked #844.

Coldstream Capital Management first reported a position in ZBH in Q4 2021 and has held it in 15 quarters since. The position peaked at $420K in Q1 2024. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Coldstream Capital Management held 4,158 shares of Zimmer Biomet worth $376K as of Q1 2026.
Coldstream Capital Management bought 1,627 Zimmer Biomet shares in Q1 2026, an estimated $149K.
Zimmer Biomet made up ﹤0.01% of Coldstream Capital Management's portfolio in Q1 2026, its #844 holding.
Coldstream Capital Management first reported a position in Zimmer Biomet in Q4 2021 and has held it in 15 quarters since.
Coldstream Capital Management's Zimmer Biomet position peaked at $420K in Q1 2024.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Coldstream Capital Management's 13F filing for Q1 2026, filed 8 May 2026.